MedTrace Logo

Observational Cohort of Pancreatic Echo-endoscopy

NCT04226014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2020-01-13

No results posted yet for this study

Summary

Metabolic syndrome is defined by the presence of at least two of the following five criteria: abdominal perimeter\> 94 cm in men, 80 cm in women, high triglycerides, low HDL cholesterol, HTA and hyperglycemia.

The metabolic syndrome can lead to ultrasound hepatic steatosis in 20 to 40% of cases depending on the population studied (overweight vs obesity). What is the impact of this syndrome on pancreatic echogenicity?

Conditions

  • Metabolic Syndrome
  • Obesity
  • Hepatic Steatosis

Interventions

PROCEDURE

Endoscopic ultrasound

Echo-endoscopy ultrasound is an examination that presents little risk. However, any medical act, exploration, intervention even conducted under conditions of competence and safety in accordance with current data of medicine and the regulations in force, conceals a risk of complications. In particular, esophageal perforations can occur. They are often favored by underlying lesions (tumor, diverticulum, anatomical variants ...). Other complications are possible such as cardiovascular, respiratory or infectious disorders, as with any anesthesia.

Sponsors & Collaborators

  • Clinique du Val d'ouest

    collaborator UNKNOWN

  • Centre Hospitalier Saint Joseph Saint Luc de Lyon

    lead OTHER

Principal Investigators

  • Anne-Marie MARION-AUDIBERT, MD, PhD · Clinique du Val d'ouest

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-17
Primary Completion
2019-04-16
Completion
2019-09-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04226014 on ClinicalTrials.gov